Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 350.00
+16.20 (4.85%)
At close: Oct 28, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 571.04 billion as of October 28, 2026. Its market cap has increased by 18.72% in one year.
Market Cap
571.04B
Enterprise Value
712.45B
Revenue
173.21B
Global Rank
n/a
Country Rank
n/a
PE Ratio
103.95
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 571.04B, an increase of 1,157.44%. That is a compound annual growth rate of 11.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 571.04B | 8.64% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 535.38B |
| Anthem Biosciences | 463.09B |
| OneSource Specialty Pharma | 160.23B |
| Concord Biotech | 137.17B |
| Blue Jet Healthcare | 91.91B |
| Supriya Lifescience | 67.05B |
| Zota Health Care | 41.39B |
| Dishman Carbogen Amcis | 21.77B |